Table 1 Characteristics of the included studies
From: Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis
Author, year | Length of follow-up | Method of outcome assessment | Grade of evidence | Subgroup | Preclosure | Postprocedural therapy |
|---|---|---|---|---|---|---|
Schwerzman et al., 2004 [25] | 1 Y | A detailed questionnaire | Low | MA | Attack frequency: 1.2 ± 0.8/M Number of large shunt: 27 | Aspirin 100 mg/d 6 M Clopidogrel 75 mg/d 1 M |
MwoA | Attack frequency: 1.2 ± 0.7/M Number of large shunt: 6 | Ditto | ||||
Azarbal et al., 2005 [21] | 1 Y | MIDAS questionnaire | Low | MA | NA | Aspirin 325 mg/d 3 M clopidogrel 75 mg/d 3 M |
MwoA | Ditto | Ditto | ||||
Slavin et al., 2007 [26] | 30 ± 16 M | MIDAS Score | Low | MA | MIDAS Score: 48.3 ± 11.8 | NA |
MwoA | MIDAS Score: 43.2 ± 11.9 | Ditto | ||||
Reisman et al., 2005 [24] | 1 Y | Migraine questionnaire | Low | MA | NA | Aspirin 325 mg/d 6 M Clopidogrel 75 mg/d 3 M |
MwoA | Ditto | Ditto | ||||
Jesurum et al., 2008 [23] | 1.5 Y | Migraine questionnaire | Low | MA | Attack frequency: 5.1 ± 7.5/M Number of large shunt: 51 | Aspirin 325 mg/d 6 M Clopidogrel 75 mg/d 3 M |
MwoA | Attack frequency: 4.8 ± 6.7/M Number of large shunt: 20 | Ditto | ||||
Dubiel et al., 2007 [22] | Mean 38 M | A structured questionnaire | Low | MA | NA | Aspirin 100 mg/d 6 M |
MwoA | Ditto | Ditto | ||||
Whal et al., 2010 [27] | 5.0 ± 1.9 Y | A structured questionnaire | Low | MA | Attack frequency: 1/d 3 Number of large shunt: 76 | Acetylsalicylic 100 mg/d 6 M Clopidogrel 75 mg/d 6 M |
MwoA | Attack frequency: 1/d 1 Number of large shunt: 46 | Ditto | ||||
Rigatelli et al., 2012 [18] | 24–76 M | MIDAS | Low | MA | Attack frequency: 1.1 ± 0.2/M | NA |
MwoA | Attack frequency: 4.2 ± 0.8/M | Ditto |